AzTrials
AzTrials

Respiratory Depression NeonatalNCT05963516

Bedside Improvement of Resuscitation Through mHealth Feedback (BIRTH Study)

A study testing LIVEBORN: A Mobile Health Application (app) for Newborn Resuscitation and NeoBeat: Heart Rate Meter for Newborn Resuscitation in people with Respiratory Depression Neonatal, run by University of North Carolina, Chapel Hill at 4 sites in Democratic Republic of the Congo.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose: To evaluate the effectiveness of newborn resuscitation feedback supported by a mobile health application called LIVEBORN; secondarily, to evaluate the relative effectiveness of real-time guidance vs debriefing. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Respiratory Depression Neonatal
What is being tested?
LIVEBORN: A Mobile Health Application (app) for Newborn Resuscitation and NeoBeat: Heart Rate Meter for Newborn Resuscitation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14,679 participants
Where
4 sitesDemocratic Republic of the Congo
Study dates
23 Aug 2023to 19 Jun 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • All in-born neonates, either liveborn or intrapartum (i.e., fresh) stillborn, regardless of multiple gestation or maternal complication.
  • All midwives and nurses functioning in the role of a midwife who care for newborns at the time of birth during the course of their regular employment.

Who cannot join

  • Less than 28 weeks completed gestation (or if gestational age is unknown, birth weight <1,000 grams),
  • outborn,
  • known congenital anomaly,
  • antepartum (i.e., macerated) stillbirth.
  • Nurse midwives employed at a participating health facility who meet the following criteria:
  • Unwillingness to consent

Trial locations and contacts

4 sites in 1 country.

Democratic Republic of the Congo4 sites
  • Binza

    Kinshasa

  • Bondo

    Kinshasa

  • Kingasani

    Kinshasa

  • Saint Gabriel

    Kinshasa

Other trials in Democratic Republic of the Congo

About this study

Purpose: To evaluate the effectiveness of newborn resuscitation feedback supported by a mobile health application called LIVEBORN; secondarily, to evaluate the relative effectiveness of real-time guidance vs debriefing.

Participants: Newborns and Nurse midwives

Procedures (methods): This is a pre-post interventional trial to evaluate the effectiveness of LIVEBORN feedback. The investigators will use a randomized design to test the relative effectiveness of two modes of feedback: real-time guidance versus debriefing. Given the potential for feedback interventions to have spillover effects, the investigators will randomize by cluster (i.e., facility) rather than by individual. The study will begin with an approximately two-month pilot phase to establish systems for implementation of recommended training and simulation practice and consistent use of LIVEBORN for observations. After these systems have been successfully established, the investigators will initiate the pre-post trial. The control phase will last six months followed by implementation of LIVEBORN feedback in an intervention phase lasting 12 months.

Read the detailed description

Study Sites:

the investigators will conduct this pre-post interventional trial in six health facilities in Kinshasa, Democratic Republic of the Congo (DRC).

Pilot Phase:

The purpose of the pilot phase is to establish systems to ensure 1) implementation of recommended training and simulation practice and 2) consistent use of LIVEBORN for observations. The pilot phase will last approximately two months. Any facilities deemed facile with LIVEBORN will be exempted from the pilot phase.

Establishment of a System for Implementation of Recommended Training and Simulation Practice: During the pilot phase, the investigators will work with each facility to ensure a system for implementation of recommended resuscitation training and low-dose high-frequency (LDHF) practice of bag-mask ventilation (BMV).

Basic Resuscitation Training: The investigators will train all nurse midwives in basic resuscitation using Helping Babies Breathe (HBB) 2.0 materials adapted to include the use of NeoBeat, a battery-operated heart rate (HR) meter. In addition to reviewing the evidence-based HBB resuscitation algorithm, research staff will orient nurse midwives to use of NeoBeat. The training will also include how to use HR to accurately distinguish liveborn from stillborn infants. The investigators will recommend that nurse midwives use NeoBeat for high-risk pregnancies and newborns not crying by 30 seconds.

Establishment of a System for Consistent Use of LIVEBORN for Observations: During the pilot phase, the investigators will work with each facility to ensure a system for consistent use of LIVEBORN for observations. This system will include placement of NeoBeat on newborns requiring resuscitation.

The investigators will use an established participatory research methodology called trials of improved practices (TIPs) which the investigators successfully used in the R21 phase of this work to design a strategy for consistent use of LIVEBORN for observations. At each facility, the investigators will conduct a strategy development session with facility leadership such as the head nurse midwife to develop an initial strategy for implementation of LIVEBORN. Each health facility will implement the locally-developed initial strategy in a small-scale test for approximately three weeks. Throughout the small-scale test, the investigators will rapidly analyze data and identify barriers to implementation of the strategy as well as potential solutions. The investigators will refine the strategy in additional cycles of TIPs (strategy development, small-scale testing, rapid analysis) until the investigators have identified a feasible strategy to move into the control phase.

Control Phase:

The purpose of the control phase is to gather detailed, prospective data on resuscitation care and newborn outcomes while implementing recommended practice. During a six-month control phase, midwives will implement HBB in their clinical practice with LDHF simulation practice of BMV. LDHF practice will occur at regular intervals per the system set up during the pilot phase. Nurse midwives will place NeoBeat on newborns that they anticipate resuscitating.

Data Collection: Research staff will conduct medical record abstraction to document clinical data for each eligible newborn including such elements as maternal parity and age, birth date and time, infant gestational age, birth weight, mode of delivery, stillborn or liveborn, alive or dead at discharge (including date of death). As in the pilot phase, trained observers (research staff, midwives, and other designated observers per the strategy developed in the pilot phase) will conduct observations of resuscitations for a convenience sample of births using the LIVEBORN app. If NeoBeat is placed on the newborn, the investigators will collect ECG data.

Preparatory Activities for the Intervention Phase: While in the control phase, the investigators will randomize facilities to either real-time guidance or debriefing with LIVEBORN in preparation for the intervention phase. Prior to implementation of the intervention and towards the end of the control phase, research staff will prepare nurse midwives to implement LIVEBORN feedback per their cluster randomized assignment using simulation.

Intervention Phase:

The purpose of the intervention phase is to gather prospective data on resuscitation care and newborn outcomes during implementation of LIVEBORN feedback. During this 12-month phase, nurse midwives will implement LIVEBORN feedback per their cluster-randomized assignment to either real-time guidance or debriefing. Additionally, nurse midwives will continue all study procedures from the control phase, including implementation of HBB with LDHF practice, use of NeoBeat on newborns requiring resuscitation, and observation of births using LIVEBORN.

Implementation of LIVEBORN Feedback: At facilities randomized to real-time guidance, midwives will be supported by audio-visual feedback from LIVEBORN during the convenience sample of resuscitations observed with LIVEBORN. At facilities randomized to debriefing, midwives will debrief with LIVEBORN for at least 50% of the convenience sample of resuscitations observed with LIVEBORN that involved a newborn not crying by 60 seconds after birth and/or the receipt of BMV.

Data Collection: As in the control phase, research staff will conduct medical record abstraction to document clinical data for each enrolled. As in the pilot and control phases, trained observers (research staff, midwives, and other designated observers per the strategy developed in the pilot phase) will conduct observations of resuscitations for a convenience sample of births using the LIVEBORN app. If NeoBeat is placed on the newborn, the investigators will collect ECG data. At the end of the intervention, five midwives \& the head nurse midwife from each facility will complete surveys consisting of 4-item quantitative scales to evaluate feasibility and acceptability using the Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM).

Being tested
LIVEBORN: A Mobile Health Application (app) for Newborn Resuscitation, NeoBeat: Heart Rate Meter for Newborn Resuscitation
Keywords
Resuscitation, Helping Babies Breathe, Debriefing, Real-Time Guidance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LIVEBORN: A Mobile Health Application (app) for Newborn ResuscitationOther

    LIVEBORN is a mobile health application designed to help providers learn from their clinical practice during newborn resuscitation through real-time guidance and debriefing. Using LIVEBORN, an observer can document events during a resuscitation such as the actions of the provider and when the baby cries. A battery-operated heart rate meter, NeoBeat, measures and sends the newborn's heart rate to the LIVEBORN app via Bluetooth. LIVEBORN integrates data from the observer and NeoBeat to provide audio-visual real-time guidance to the provider during a resuscitation. Following the resuscitation, providers can also debrief using LIVEBORN. The app operates on the Android system and is functional off-line, except for the need for an internet connection to upload data to the cloud for research.

  • NeoBeat: Heart Rate Meter for Newborn ResuscitationDevice

    NeoBeat is a low-cost device for the measurement of newborn heart rate (HR) that was developed by Laerdal Global Health for use in low-resource settings. It is applied by placing the device around the torso of the newborn. It detects HR accurately, quickly (<5 sec), is reusable and can be easily disinfected. NeoBeat's dry electrodes detect HR which is digitally displayed and recorded. It uses an impedance system to sense skin contact and motion detection to validate signal quality. It does not require the use of buttons, adhesive, gel or cables and has no disposable parts. A single birth attendant can apply NeoBeat in 2-3 seconds.

Study groups in NCT05963516
Study groupRoleWhat they receive
Real-time GuidanceActive comparatorThe LIVEBORN app will provide audio-visual guidance to the birth attendant during a resuscitation based on the data inputted by an observer as well as heart rate data from NeoBeat (if used).
Receives: Other: LIVEBORN: A Mobile Health Application (app) for Newborn Resuscitation; Device: NeoBeat: Heart Rate Meter for Newborn Resuscitation
DebriefingActive comparatorThe LIVEBORN app will support birth attendants in debriefing following a resuscitation based on the data inputted by an observer as well as heart rate data from NeoBeat (if used).
Receives: Other: LIVEBORN: A Mobile Health Application (app) for Newborn Resuscitation; Device: NeoBeat: Heart Rate Meter for Newborn Resuscitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Duration of Suctioning Among All Live Births

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  2. Median Duration of Suctioning Among All Live Births

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

Secondary outcomes (18)
  1. Mean Duration of Suctioning Among Live Births Not Crying By 30 Seconds

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates not crying by 30 seconds. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  2. Median Duration of Suctioning Among Live Births Not Crying By 30 Seconds

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates not crying by 30 seconds. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  3. Proportion Suctioned For <30 Seconds Among Live Births Not Crying By 30 Seconds

    The investigators will report the proportion of live births not crying by 30 seconds who are suctioned for less than 30 seconds. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  4. Mean Time to Bag Mask Ventilation (BMV) Among Live Births Not Crying By 30 Seconds Who Receive BMV

    The investigators will measure time to BMV as a continuous variable, defining time to BMV as the number of seconds between birth and the start of BMV. They will report time to BMV among all livebirths not crying by 30 seconds who receive BMV. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  5. Median Time to Bag Mask Ventilation (BMV) Among Live Births Not Crying By 30 Seconds Who Receive BMV

    The investigators will measure time to BMV as a continuous variable, defining time to BMV as the number of seconds between birth and the start of BMV. They will report time to BMV among all livebirths not crying by 30 seconds who receive BMV. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  6. Proportion Who Receive Bag Mask Ventilation (BMV) Within 1 Minute Among Live Births Not Crying By 30 Seconds Who Receive BMV

    The investigators will report a dichotomous variable of BMV initiation within 60 seconds after birth. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  7. Proportion Who Receive Bag Mask Ventilation (BMV) Within 2 Minutes Among Live Births Not Crying By 30 Seconds Who Receive BMV

    The investigators will report a dichotomous variable of BMV initiation within 120 seconds after birth. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  8. Proportion Who Receive Bag Mask Ventilation (BMV) Among Live Births Not Crying By 60 Seconds

    The investigators will measure a dichotomous variable of receipt of BMV at any point during delivery room resuscitation among liveborn infants who do not cry by 60 seconds after birth. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  9. Mean Duration of Suctioning Among Live Births Crying By 30 Seconds

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates crying by 30 seconds. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  10. Median Duration of Suctioning Among Live Births Crying By 30 Seconds

    The investigators will measure duration of suctioning as a continuous variable among liveborn neonates crying by 30 seconds. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  11. Proportion Suctioned Among Live Births Crying By 30 Seconds

    The investigators will report the proportion of livebirths crying by 30 seconds who are suctioned. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  12. Mean Time to Heart Rate ≥ 100 Beats Per Minute Among Live Births Not Crying By 30 Seconds Who Have NeoBeat Placed and First HR < 100 Bpm

    The investigators will measure the time to HR≥100bpm as a continuous variable among livebirths who have not cried by 30 seconds after birth who have NeoBeat placed. This variable will be collected using NeoBeat.

    Measured: First hour after birth

  13. Median Time to Heart Rate ≥ 100 Beats Per Minute Among Live Births Not Crying By 30 Seconds Who Have NeoBeat Placed and First HR < 100 Bpm

    The investigators will measure the time to HR≥100bpm as a continuous variable among livebirths who have not cried by 30 seconds after birth who have NeoBeat placed. This variable will be collected using NeoBeat.

    Measured: First hour after birth

  14. Mean Time to First Cry Among Live Births Not Crying By 30 Seconds

    The investigators will measure time from birth to first cry as a continuous variable among liveborn infants who have not cried by 30 seconds after birth. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  15. Median Time to First Cry Among Live Births Not Crying By 30 Seconds

    The investigators will measure time from birth to first cry as a continuous variable among liveborn infants who have not cried by 30 seconds after birth. This variable will be collected via direct observation using the Liveborn application.

    Measured: First hour after birth

  16. Proportion of 24-Hour Newborn Mortality Among Live Births

    The investigators will measure 24-hour newborn mortality as a dichotomous variable for all enrolled newborns. In the participating Health Facilities, typical length of stay following birth is more than 24 hours. In the rare instance when a newborn is discharged home prior to 24 hours after birth, the investigators will assume the newborn is alive at 24 hours. If the newborn is transferred prior to discharge, the investigators will contact the referral facility to determine 24-hour vital status.

    Measured: Between birth and 24 hours of age

  17. Proportion of Perinatal Mortality Among All Births

    The investigators will define fresh stillbirths based on the provider's documentation in the medical record. The investigators will measure perinatal mortality as a dichotomous variable for all enrolled newborns.

    Measured: Between birth and 24 hours of age

  18. Proportion of Stillborn Misclassification Among Stillbirths Directly Observed at Birth

    The investigators will review the subset of stillbirth cases with heart rate (HR) data from NeoBeat to determine whether the case is stillborn or liveborn based on HR. The investigators will define misclassification as cases identified by a provider as stillborn who have a HR per NeoBeat. The investigators will measure the dichotomous outcome of stillbirth misclassification and report the proportion who were misclassified.

    Measured: At birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2023
  2. Study start23 Aug 2023
  3. Primary completion22 May 2025
  4. Study completion19 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
14,679 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05963516
Sponsor's protocol ID
23-0267
Other IDs
R33HD103058, IGHID 12309
Status last verified
Aug 2025
First submitted
17 Jul 2023
Last updated
28 Sep 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: A de-identified dataset will be posted onto a suitable publicly available archive.

Questions about this trial

What is this clinical trial studying?

A study testing LIVEBORN: A Mobile Health Application (app) for Newborn Resuscitation and NeoBeat: Heart Rate Meter for Newborn Resuscitation in people with Respiratory Depression Neonatal, run by University of North Carolina, Chapel Hill at 4 sites in Democratic Republic of the Congo.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Democratic Republic of the Congo. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 May 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Duration of Suctioning Among All Live Births (time frame: First hour after birth). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in